Dynamic Parameters of Glucose Control in Relation to Biomarkers in Serum and Intraocular Fluid in Patients With Diabetes - Trial NCT05944640
Access comprehensive clinical trial information for NCT05944640 through Pure Global AI's free database. This phase not specified trial is sponsored by Charles University, Czech Republic and is currently Recruiting. The study focuses on Diabetes Complications. Target enrollment is 213 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Charles University, Czech Republic
Timeline & Enrollment
N/A
Apr 01, 2022
Jun 01, 2026
Primary Outcome
miRNA,TIR
Summary
Our project investigates the new characteristics of diabetic retinopathy using liquid eye
 biopsy in combination with novel parameters of glucose control obtained with continuous
 glucose monitoring. This approach will bring new knowledge and implications for future
 therapies.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05944640
Non-Device Trial